ChinaDaily Briefs

Daily Brief China: Get Nice Financial Group Ltd, Sun Art Retail, Eva Airways, Wuxi Biologics, Jumppoint and more

In today’s briefing:

  • Get Nice Financial (1469 HK): Attractive Spread Ahead of Get Nice Holdings (64 HK)’s EGM Vote
  • (Mostly) Asia-Pac M&A: Sun Art Retail, AVJennings, Shandong Hi-Speed New Energy, Boqi, Get Nice
  • Quick Update on Asian Air Cargo Trends: No Signs of Market Tightness in These Numbers
  • China Healthcare Weekly (Jan.5)-TCM VBP Update, Medical Device VBP Result Is Out, WuXi Bio’s Outlook
  • Jumppoint bags US$3.5M to streamline logistics for e-commerce in SEA | e27


Get Nice Financial (1469 HK): Attractive Spread Ahead of Get Nice Holdings (64 HK)’s EGM Vote

By Arun George

  • The Get Nice Financial Group Ltd (1469 HK)/GNF offer is conditional on the approval by GNH/GNF shareholders. Get Nice Holdings (64 HK)/GNH’s shareholder vote is on 22 January. 
  • The GNH vote will comfortably pass as Mr Hung, the controlling shareholder, represents 66.11% of outstanding shares, just shy of the 66.67% required voting threshold.   
  • The implied offer value has declined by 10%, broadly in line with the median decline in peer share prices. Therefore, the scheme vote remains low-risk. 

(Mostly) Asia-Pac M&A: Sun Art Retail, AVJennings, Shandong Hi-Speed New Energy, Boqi, Get Nice

By David Blennerhassett


Quick Update on Asian Air Cargo Trends: No Signs of Market Tightness in These Numbers

By Daniel Hellberg

  • Tracking Asian air cargo trends can uncover investment opportunities & offer read-throughs
  • In November 2024, no clear signs of market tightness in data from Taiwanese, Chinese carriers
  • A quick look at numbers from CX, SIA, LAX also suggests ample available cargo space

China Healthcare Weekly (Jan.5)-TCM VBP Update, Medical Device VBP Result Is Out, WuXi Bio’s Outlook

By Xinyao (Criss) Wang

  • The third batch of VBP results of the National TCM Patent Medicines were released. Some products experienced over 90% price reduction. The price decline of exclusive varieties was moderate.
  • The VBP results of cochlear implants and peripheral vascular stents were released. Both foreign and domestic companies participated in the VBP actively, hoping to increase market share in China. 
  • The key is to see whether 2024 full-year performance can meet expectations, which is the bottom line for WuXi Bio. Without a definitive long-term logic, short-term trading is recommended.

Jumppoint bags US$3.5M to streamline logistics for e-commerce in SEA | e27

By e27

  • Hong Kong-based cross-border e-commerce logistics startup Jumppoint has secured an additional US$3.5 million in Series A+ funding, bringing its total funding to US$20 million.
  • The news round was led by returning investor MindWorks Capital, with participation from other investors, including IMM Global, Headline Asia, the Hong Kong Government, Beyond Ventures, Chinachem Group, and Boon Ventures.
  • The funding will be used to scale Jumppoint’s AI-driven logistics platform, expand its regional network, and enhance its service offerings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars